States Limiting Patient Costs for High-Priced Drugs

  • July 02, 2015
Some states are capping patients’ copayments for expensive specialty drugs, but at the cost of higher premiums for everyone. Read More
Copy the URL for use in an RSS reader:

3.5%

Growth in states’ buying power since the Great Recession based on tax revenue gains.

Learn more at Pew’s Fiscal 50

About Stateline

Stateline covers issues that are key to state policy: health care, demographics, the business of government, and fiscal issues.

Learn more

Explore